Ancient Skeleton Shows Leprosy May Have Spread to Britain from Scandinavia
The team, led by the University of Leiden, and including researchers from Historic England and the universities of Southampton, Birmingham, Surrey, and Swansea, examined a 1500 year old male skeleton, excavated at Great Chesterford in Essex, England during the 1950s.
Archaeologist Dr Sonia Zakrzewski, of the University of Southampton, explains DNA testing was necessary to get a clear diagnosis: “Not all cases of leprosy can be identified by changes to the skeleton. Some may leave no trace on the bones; others will affect bones in a similar way to other diseases. In these cases the only way to be sure is to use DNA fingerprinting, or other chemical markers characteristic of the leprosy bacillus.”
The researchers tested the skeleton for bacterial DNA and lipid biomarkers to confirm the man had definitely had leprosy and to allow them to carry out a detailed genetic study of the bacteria that caused his illness.
Professor Mike Taylor, a Bioarchaeologist from the University of Surrey, says: “Not every excavation yields good quality DNA, but in this case, leprosy DNA isolated from the skeleton was so good it enabled us to identify its strain.”
The results showed the leprosy strain belonged to a lineage (3I) which has previously been found in burials from Medieval Scandinavia and southern Britain, but in this case it originates from a much earlier period, dating from the 5th or 6th centuries AD.
The identification of fatty molecules (lipids) from the leprosy bacteria confirmed the DNA results and also showed it was different from later strains. Emeritus scientist David Minnikin, from the University of Birmingham, says: “With Leverhulme Trust support, we recorded strong profiles of fatty acid lipid biomarkers that confirmed the presence of leprosy. However, one class of the lipid biomarkers had distinct profiles that may distinguish these older leprosy cases from later Medieval examples.”
Isotopes from the man’s teeth showed that he probably did not come from Britain, but more likely grew up elsewhere in northern Europe, perhaps southern Scandinavia. This matched the results of the DNA, and raises the intriguing possibility that he brought a Scandinavian strain of the leprosy bacterium with him when he migrated to Britain.
Project leader Dr Sarah Inskip of Leiden University concludes: “The radiocarbon date confirms this is one of the earliest cases in the UK to have been successfully studied with modern biomolecular methods. This is exciting both for archaeologists and for microbiologists. It helps us understand the spread of disease in the past, and also the evolution of different strains of disease, which might help us fight them in the future. We plan to carry out similar studies on skeletons from different locations to build up a more complete picture of the origins and early spread of this disease.”
Although leprosy is nowadays a tropical disease, in the past it occurred in Europe. Human migrations probably helped spread it, and there are cases in early skeletons from western Europe, particularly from the 7th century AD onward. However the origins of these ancient cases are poorly understood. The study of the Great Chesterford skeleton provided an important opportunity to shed light on the early spread of leprosy.
The results of the study will be published in the journal PLOS ONE and copies of the paper can be requested from Media Relations.
Source: http://www.ineffableisland.com/2015/05/ancient-skeleton-shows-leprosy-may-have.html
Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.
"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.
LION'S MANE PRODUCT
Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules
Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.
Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.
